Manuel Quaresma
- Interim analysis of nintedanib in an open-label extension of the INPULSIS® trials (INPULSIS®-ON)By Bruno Crestani, Takashi Ogura, Katy Pelling, Carl Coeck, Manuel Quaresma, Michael Kreuter and Mitchell KayeBruno Crestani1Pneumologie, Hôpital Bichat, Paris, FranceTakashi Ogura2Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa JapanKaty Pelling3Statistics, Boehringer Ingelheim Ltd., Bracknell, United KingdomCarl Coeck4Respiratory Diseases, SCS Boehringer Ingelheim Comm.V., Brussels, BelgiumManuel Quaresma5Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG., Ingelheim am Rhein, GermanyMichael Kreuter6Department of Pneumology, Thoraxklinik, University of Heidelberg, and Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, GermanyMitchell Kaye7Minnesota Lung Center, Ltd., Minnesota Lung Center, Ltd., Minneapolis, MN United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.